SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Pfizer Inc. (JOBS) Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer